OpenURL Connection Search

Select item for more details and to access through your institution.

Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.
Published in:
Current Oncology, 2019, v. 26, n. 4, p. E551, doi. 10.3747/co.26.5137
By:
- Bebb, D. G.;
- Agulnik, J.;
- Albadine, R.;
- Banerji, S.;
- Bigras, G.;
- Butts, C.;
- Couture, C.;
- Cutz, J. C.;
- Desmeules, P.;
- Ionescu, D. N.;
- Leighl, N. B.;
- Melosky, B.;
- Morzycki, W.;
- Rashid-Kolvear, F.;
- Sekhon, H. S.;
- Smith, A. C.;
- Stockley, T. L.;
- Torlakovic, E.;
- Xu, Z.;
- Tsao, M. S.
Publication type:
Article
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Published in:
Current Oncology, 2018, v. 25, n. 5, p. 317, doi. 10.3747/co.25.4379
By:
- Melosky, B.;
- Cheema, P.;
- Agulnik, J.;
- Albadine, R.;
- Bebb, D. G.;
- Blais, N.;
- Burkes, R.;
- Butts, C.;
- Card, P. B.;
- Chan, A. M. Y.;
- Hirsh, V.;
- Ionescu, D. N.;
- Juergens, R.;
- Morzycki, W.;
- Poonja, Z.;
- Sangha, R.;
- Tehfe, M.;
- Tsao, M. S.;
- Vincent, M.;
- Xu, Z.
Publication type:
Article
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Published in:
Current Oncology, 2016, v. 23, n. 3, p. 196, doi. 10.3747/co.23.3120
By:
- Melosky, B.;
- Agulnik, J.;
- Albadine, R.;
- Banerji, S.;
- Bebb, D. G.;
- Bethune, D.;
- Blais, N.;
- Butts, C.;
- Cheema, P.;
- Cheung, P.;
- Cohen, V.;
- Deschenes, J.;
- Ionescu, D. N.;
- Juergens, R.;
- Kamel-Reid, S.;
- Laurie, S. A.;
- Liu, G.;
- Morzycki, W.;
- Tsao, M. S.;
- Xu, Z.
Publication type:
Article

Found: 3

Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.

Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.